Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
Transpek Industry's 5-Year RORE % for the quarter that ended in Jun. 2026 was -12.96%.
The industry rank for Transpek Industry's 5-Year RORE % or its related term are showing as below:
BOM:506687's 5-Year RORE % is ranked worse than 64.38% of 1440
companies
in the Chemicals industry
Industry Median: 0.935
vs BOM:506687: -12.96
Transpek Industry (BOM:506687) 5-Year RORE % Explanation
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 5-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
Transpek Industry 5-Year RORE % Related Terms
Transpek Industry 5-Year RORE % Historical Data
* Premium members only.
The historical data trend for Transpek Industry's 5-Year RORE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Transpek Industry's 5-Year RORE %, along with its competitors' market caps and 5-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Transpek Industry 5-Year RORE % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Transpek Industry's 5-Year RORE % distribution charts can be found below:
* The bar in red indicates where Transpek Industry's 5-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 5-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Jun. 2026 and 5-year before.
Transpek Industry (BOM:506687) has a 5-Year RORE % of -12.96 as of Jun. 2026. 5-Year RORE % shows how much a company earns by reinvesting its retained earnings in 5-year. View historical data on Transpek Industry and its competitors. According to the industry distribution chart, Transpek Industry ranks #927 out of 1440 companies in the Chemicals industry, placing it in the top 64.4%.
Is Transpek Industry's 5-Year RORE % too high?
Transpek Industry's current 5-Year RORE % is -12.96. Based on the distribution chart, Transpek Industry ranks #927 out of 1440 companies in the Chemicals industry, which is below the industry midpoint. Overall, Transpek Industry has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Transpek Industry's 5-Year RORE % compare to DOW?
According to the Chemicals industry distribution chart, Transpek Industry ranks #927 out of 1440 companies for 5-Year RORE %. This places Transpek Industry in the lower half of its industry. The industry median 5-Year RORE % is 0.94. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year RORE % for a Chemicals company?
The median 5-Year RORE % among Chemicals companies is 0.94, based on 1,440 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year RORE % mean?
A high 5-Year RORE % can signal that a stock is expensive relative to its fundamentals. 5-Year RORE % shows how much a company earns by reinvesting its retained earnings in 5-year. View historical data on Transpek Industry and its competitors. For the Chemicals industry, the median 5-Year RORE % is 0.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Transpek Industry's current 5-Year RORE % is -12.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Transpek Industry stock overvalued right now?
Based on GuruFocus' analysis, Transpek Industry (BOM:506687) is currently considered Fairly Valued. The stock's GF Value™ is ₹1,509.40, compared to a current price of ₹1,436.25 — trading 4.8% below its estimated fair value. The current 5-Year RORE % is -12.96. Transpek Industry's overall GF Score™ is 77/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year RORE % calculated?
5-Year RORE % is calculated from a company's financial statements. For Transpek Industry (BOM:506687), the current 5-Year RORE % is -12.96 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Transpek Industry (BOM:506687) Overvalued in 2026?
Based on GuruFocus' analysis, Transpek Industry stock appears to be undervalued.
The current stock price of ₹1,436.25 is trading 4.8% below its estimated GF Value™ of ₹1,509.40.
GuruFocus considers Transpek Industry to be Fairly Valued.
Key valuation signals for BOM:506687:
5-Year RORE %: -12.96
GF Value™: ₹1,509.40 vs. price of ₹1,436.25 (4.8% below fair value)
No single metric tells the full story. See the BOM:506687 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Transpek Industry Ltd is a chemical manufacturing company which engages in the manufacturing and export of a range of Chemicals; Pesticides; Organic compounds. The Company is engaged in the business of manufacturing of Chemicals which is the only operating Segment. These products are used in various industrial applications, such as polymers, plastics, performance materials, agrochemicals, pharmaceuticals, and Other Applications. The group sells its products in India and also exports to other countries, of which key revenue is derived from North America.
77GF Score
Get the complete analysis for BOM:506687
5-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:506687 has been successfully added to your 
